Extracellular matrix of peripheral nerves in diabetes

Journal of the Peripheral Nervous System

Volumn 2, Issue 3, 1997, Pages 213-226

  Peltonen, Juha T ^a,b   Kalliomäki, Marko A ^b   Muona, Päivi K M ^b  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Basement membrane; Collagen; Connective tissue; Diabetic neuropathy; Glucose transporter; Hyperglycemia; Perineurial cell; Schwann cell

Indexed keywords

ANIMAL; CONNECTIVE TISSUE; DIABETIC NEUROPATHY; EXTRACELLULAR MATRIX; HUMAN; INNERVATION; METABOLISM; PATHOLOGY; PERIPHERAL NERVE; REVIEW; ULTRASTRUCTURE;

ANIMALS; CONNECTIVE TISSUE; DIABETIC NEUROPATHIES; EXTRACELLULAR MATRIX; HUMANS; PERIPHERAL NERVES;

EID: 0031290558     PISSN: 10859489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (152)

1. Jakobsen J: Peripheral nerves in early experimental diabetes: expansion of endoneurial space as a cause of increased water content. Diabetologia 1978; 14:113-119.
2. Johnson PC, Doll SC, Cromey DW: Pathogenesis of diabetic neuropathy. Ann. Neurol. 1986; 19:450-457.
3. Johnson PC, Brendel K, Meezan E: Human diabetic perineurial cell basement membrane thickening. Lab. Invest. 1981; 44:265-270.
4. Bischoff A: Diabetic neuropathy. Morbid anatomy, pathophysiology and pathogenesis based on electron-microscopic findings. German Medical Monthly 1968; 13:214-218.
5. Bradley J, Thomas PK, King RHM, Llewelyn JG, Muddle JR, Watkins PJ: Morphometry of endoneurial capillaries in diabetic sensory and autonomie neuropathy. Diabetologia 1990; 33:611-618.
6. King RHM, Llewelyn JG, Thomas PK, Gilbey SG, Watkins PJ: Diabetic neuropathy: Abnormalities of Schwann cell and perineurial basal laminae. Implications for diabetic vasculopathy. Neuropathol. Appl. Neurobiol. 1989; 15:339-355.
7. Powell H, Know D, Lee S, Charters AC, Orloff M, Garrett R, Lambert P: Alloxan diabetic neuropathy: electron microscopic studies. Neurology 1977; 27:60-66.
8. Powell HC, Rosoff J, Myers RR: Microangiopathy in human diabetic neuropathy. Acta Neuropathol. 1985; 68:295-305.
9. Sima AAF, Lorusso AC, Thibert P: Distal symmetric polyneuropathy in the spontaneously diabetic BB-Wistar rat. An ultrastructural and teased fiber study. Acta Neuropathol. (Berl.) 1982; 58:39-47.
10. Timpl R, Brown, J: Supramolecular assembly of basement membranes. BioEssays 1996; 18:123-132.
11. Yurchenco PD, Schittny JC: Molecular architecture of basement membranes. FASEB J. 1990; 4:1577-1590.
12. Yurchenco PD, O'Rear J: Supramolecular organization of basement membranes. In: Molecular and Cellular Aspects of Basement Membranes (Rohrbach DH, Timpl R, eds). San Diego: Academic Press, 1993, pp 19-47.
13. Muona P, Jaakkola S, Salonen V, Peltonen J: Diabetes induces the formation of large diameter collagen fibrils in the sciatic nerves of BB rats. Matrix 1989; 9:63-67.
14. Salonen V, Lehto M, Vaheri A, Aro H, Peltonen J: Endoneurial fibrosis following nerve transection. Acta Neuropathol. (Berl.) 1985; 67:315-321.
15. Fleischmajer R, Olsen BR, Timpl R, Perlish JS, Lovelace O: Collagen fibril formation during embryogenesis. Proc. Natl. Acad. Sci. USA 1983; 80:3354-3358.
16. Fleischmajer R, Perlisch JS, Burgeson RE, Shaikh-Bahai F, Timpl R: Type I and III collagen interactions during fibrillogenesis. Ann. N.Y. Acad. Sci. 1990; 580: 161-175.
17. Muona P, Jaakkola S, Zhang R-Z, Pan T-C, Pelliniemi L, Risteli L, Chu M-L, Uitto J, Peltonen J: Hyperglycemic glucose concentrations up-regulate the expression of type VI collagen in vitro: Relevance to alterations of peripheral nerves in diabetes mellitus. Am. J. Pathol. 1993; 142:1586-1597.
18. Luse SA: Electron microscopic studies of brain tumors. Neurology 1960; 10:881-905.
19. Bruns RR: Beaded filaments and long-spacing fibrils: Relation to type VI collagen. J. Ultrastruct. Res. 1984; 89:136-145.
20. Bruns RR, Press W, Engvall E, Timpl R, Gross J: Type VI collagen in extracellular, 100-nm periodic filaments and fibrils: identification by immunoelectron microscopy. J. Cell Biol. 1987; 103:393-104.
21. van der Rest M, Garrone R: Collagen family of proteins. FASEB J. 1991; 5:2814-2823.
22. Kielty CM, Hopkinson I, Grant ME: Collagen: The collagen family: Structure, assembly, and organization in the extracellular matrix. In: Connective Tissue and Its Heritable Disorders. Molecular, Genetics, and Medical Aspects (Royce PM, Steinmann B, eds). New York: Wiley-Liss Inc., 1993, pp 103-147.
23. Prockop DJ, Kivirikko KI: Collagens: Molecular biology, diseases, and potentials for therapy. Annu. Rev. Biochem. 1995; 64:403-434.
24. The DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1994; 329: 977-986.
25. Thomas PK: The connective tissue of peripheral nerve: an electron microscope study. J. Anat. 1963; 97:35-44.
26. Gamble HJ: Comparative electron-microscopic observations on the connective tissues of a peripheral nerve and a spinal nerve root in the rat. J. Anat. 1964; 98:17-25.
27. Gamble HJ, Eames RA: An electron microscope study of the connective tissues of human peripheral nerve. J. Anat. 1964; 98:655-663.
28. Haftek J: Stretch injury of peripheral nerve. J. Bone Joint Surg. 1970; 52:354-365.
29. Thomas PK, Olsson Y: Microscopic anatomy and function of the connective tissue components of peripheral nerve. In: Peripheral Neuropathy. (Dyck PJ, Thomas PK, Lambert EH, Bunge RP, eds). Philadelphia, WB Saunders: 1984; pp 97-120.
30. Shellswell GB, Restall DJ, Duance VC, Bailey AJ: Identification and differential distribution of collagen types in the central and peripheral nervous systems. FEBS Lett. 1979; 106:305-308.
31. Farquhar MG: The glomerular basement membrane: a selective macromolecular filter. In: Cell Biology of Extracellular Matrix (Hay ED, ed). New York: Plenum, 1981.
32. Oldfors A: Macrophages in peripheral nerves. An ultrastructural and enzyme histochemical study on rats. Acta Neuropathol. (Berl.) 1980; 49:43-49.
33. Bardosi A, Dimitri T, Behrends T, Autschbach D, Gabius H-J: Is part of the molecular basis of the perineurial barrier function the lack of endogenous carbohydrate-binding proteins? J. Neurosci. Res. 1989; 22:65-73.
34. Rohrbach DH, Murrah VA: Molecular aspects of basement membrane pathology. In: Molecular and Cellular Aspects of Basement Membranes (Rohrbach DH, Timpl R, eds). San Diego: Academic Press, 1993, pp 385-419.
35. Tryggvason K: Biochemistry and genetic diseases of glomerular basement membrane. Semin. Nephrol. 1993; 13:447-456.
36. Martinez-Hernandez A, Amenta PS: The basement membrane in pathology. Lab. Invest. 1983; 48:656-677.
37. Sage EH, Bornstein P: Extracellular proteins that modulate cell-matrix interactions: SPARC, tenascin, and thrombospondin. J. Biol Chem. 1991; 266:14831-14834.
38. Trüeb B, Gröbli B, Spiess M, Odermatt BF, Winterhalter KH: Basement membrane (type IV) collagen is a heteropolymer. J. Biol. Chem. 1982; 257:5239-5245.
39. Butkowski R, Langeveld JPM, Wieslander J, Hamilton J, Hudson BG: Localization of the Goodpasture epitope to a novel chain of basement membrane collagen. J. Biol. Chem. 1987; 262:7874-7877.
40. Hostikka SL, Eddy RL, Byers MG, Höyhtyä M, Shows TB, Tryggvason K: Identification of a distinct type IV collagen alpha chain with restricted kidney distribution and assignment of its gene to the locus of X-chromosome-linked Alport syndrome. Proc. Natl. Acad. Sci. USA 1990; 87:1606-1610.
41. Pihlajaniemi T, Pohjolainen ER, Myers JC: Complete primary structure of the triple-helical region and the carboxyl-terminal domain of a new type IV collagen chain, α5(IV). J. Biol. Chem. 1990; 265:13758-13766.
42. Oohashi T, Sugimoto M, Mattei MG, Ninomiya Y: Identification of a new collagen IV chain, α6(IV), by cDNA isolation and assignment of the gene to chromosome Xq22, which is the same locus for COL4A5. J. Biol. Chem. 1994; 269:7520-7526.
43. Zhou J, Leinonen A, Tryggvason K: Structure of the human type IV collagen COL4A5 gene. J. Biol. Chem. 1994; 269:6608-6614.
44. Zhou J, Ding M, Zhao Z, Reeders ST: Complete primary structure of the sixth chain of human basement membrane collagen, α6(IV). J. Biol. Chem. 1994; 269: 13193-13199.
45. Sanes JR, Engvall E, Butkowski R, Hunter DD: Molecular heterogeneity of basal laminae: isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere. J. Cell Biol. 1990; 111:1685-1699.
46. Jaakkola S, Savunen O, Halme T, Uitto J, Peltonen J: Basement membranes during development of human nerve: Schwann cells and perineurial cells display marked changes in their expression profiles for laminin subunits and β1 and β4 integrins. J. Neurocytol. 1993; 22:215-230.
47. Leivo I, Engvall E: Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development. Proc. Natl. Acad. Sci. USA 1988; 85:1544-1548.
48. Hunter DD, Shah B, Merlie JP, Sanes JR: A laminin-like adhesive protein concentrated in the synaptic cleft of the neuromuscular junction. Nature 1989; 338:229-234.
49. Hsiao LL, Peltonen J, Jaakkola S, Gralnick H, Uitto J: Plasticity of integrin expression by nerve-derived connective tissue cells: Human Schwann cells, perineurial cells, and fibroblasts express markedly different patterns of β1 integrins during nerve development, neoplasia, and in vitro. J. Clin. Invest. 1991; 87:811-820.
50. Niessen CM, Cremona O, Daams H, Ferraresi S, Sonnenberg A, Marchisio PC: Expression of the integrin alpha 6 beta 4 in peripheral nerves: localization in Schwann and perineural cells and different variants of the β4 subunit. J. Cell Sci. 1994; 107:543-552.
51. Feltri ML, Scherer SS, Nemni R, Kamholz J, Vogelbacker H, Scott MO, Canal N, Quaranta V, Wrabetz L: Beta 4 integrin expression in myelinating Schwann cells is polarized, developmentally regulated and axonally dependent. Development 1994; 120:1287-1301.
52. Cohen MP, Surma ML, Wu V-Y: In vivo biosynthesis and turnover of glomerular basement membranes in diabetic rats. Am. J. Physiol. 1982; 242:385-389.
53. Hasslacher C, Kopischke HG, Bürklin E, Gechter F, Timpl R: In vivo studies on basement membrane synthesis in diabetic and nondiabetic rats. Res. Exp. Med. 1982; 181:245-251.
54. Falk RJ, Scheinman JI, Mauer SM, Michael AF: Poly-antigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes 1983; 32 [Suppl 2]:34-39.
55. Ledbetter S, Copeland EJ, Noonan D, Vogeli G, Hassell JR: Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthase inhibition. Diabetes 1990; 39:196-203.
56. Roy S, Maiello M, Lorenzi M: Increased expression of basement membrane collagen in human diabetic retinopathy. J. Clin. Invest. 1994; 93:438-442.
57. Sohar E, Ravid M, Ben-Shaul Y, Reshef T, Gafni J: Diabetic fibrillosis. A report of three cases. Am. J. Med. 1970; 49:64-69.
58. Hsu H-C, Churg J: Glomerular microfibrils in renal disease: a comparative electron microscopic study. Kidney Int. 1979; 16:497-504.
59. Bruneval P, Foidart JM, Nochy D, Camilleri JP, Bariety J: Glomerular matrix proteins in nodular glomerulosclerosis in association with light chain deposition disease and diabetes mellitus. Hum. Pathol. 1985; 16: 477-484.
60. Hessle H, Engvall E: Type VI collagen. Studies on its localization, structure, and biosynthetic form with monoclonal antibodies. J. Biol. Chem. 1984; 259: 3955-3961.
61. Kielty CM, Boot-Handford RP, Ayad S, Shuttleworth CA, Grant ME: Molecular composition of type VI collagen: Evidence for chain heterogeneity in mammalian tissues and cultured cells. Biochem. J. 1990; 272:787-795.
62. Olsen D, Peltonen J, Jaakkola S, Chu M-L and Uitto J: Collagen gene expression by cultured human skin fibroblasts: Abundant steady-state levels of type VI procollagen messenger RNAs. J. Clin. Invest 1989; 83:791-795.
63. Keene DR, Engvall E, Glanville RW: Ultrastructure of type VI collagen suggests an anchoring function for this filamentous network. J. Cell Biol. 1988; 107: 1995-2006.
64. Peltonen J, Jaakkola S, Hsiao LL, Timpl R, Chu M-L, Uitto J: Type VI collagen. In situ hybridizations and immunohistochemistry reveal abundant mRNA and protein levels in human neurofibroma, schwannoma and normal peripheral nerve tissues. Lab. Invest. 1990; 62:487-492.
65. Hirvonen O, Peltonen S, Hirvonen H, Björkstrand A-S, Peltonen J: Expression of laminin and collagen genes by cells cultured from developing human sciatic nerves. J. Periph. Nerv. Syst. 1996; 1:42-52.
66. Fleischmajer R, Timpl R, Dziadek M, Lebwohl M: Basement membrane proteins, interstitial collagens, and fibronectin in neurofibroma. J. Invest. Dermatol. 1985; 85:54-59.
67. Peltonen J, Hsiao LL, Jaakkola S, Sollberg S, Aumailley M, Timpl R, Chu M-L, Uitto J: Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-β1 mRNA. J. Invest. Dermatol. 1991; 97:240-248.
68. Sollberg S, Muona P, Lebwohl M, Peltonen J, Uitto J: Presence of type I and VI collagen mRNAs in endothelial cells in cutaneous neurofibromas. Lab. Invest. 1991; 65:237-242.
69. Engel J, Furthmayr H, Odermatt E, von der Mark H, Aumailley M, Fleischmajer R, Timpl R: Structure and macromolecular organization of type VI collagen. Ann. N.Y. Acad. Sci. 1985; 460:25-37.
70. Engvall E, Hessle H, Klier G: Molecular assembly, secretion, and matrix deposition of type VI collagen. J. Cell Biol. 1986; 102:703-710.
71. Lassmann H, Gebhart W, Stockinger L: The reaction of connective tissue fibers in the tumor of von Recklinghausen's disease. Virchows Arch. (Cell Pathol.) 1975; 19:167-177.
72. Pillai PA: A banded structure in the connective tissue of nerve. J. Ultrastruct. Res. 1964; 11:455-468.
73. Oda Y, Kawahara E, Minamoto T, Ueda Y, Ikeda K, Nagai Y, Nakanishi I: Immunohistochemical studies on the tissue localization of collagen types I, III, IV, V and VI in schwannomas. Virchows Arch. (Cell Pathol.) 1988; 56:153-163.
74. Okada Y, Naka K, Minamoto T, Ueda Y, Oda Y, Nakanishi I, Timpl R: Localization of type VI collagen in the lining cell layer of normal and rheumatoid synovium. Lab. Invest. 1990; 63:647-656.
75. Salonen V, Röyttä M, Peltonen J: The effects of nerve transection on the endoneurial collagen fibril sheaths. Acta Neuropathol. (Berl) 1987; 74:13-21.
76. Berthold CH: Morphology of normal peripheral axons. In: Physiology and Pathology of Axons (Waxman SG, ed). New York: Raven Press, 1978.
77. Poduslo JF, Curran GL, Dyck PJ: Increase in albumin, IgG, and IgM blood-nerve indices in human diabetic neuropathy. Proc. Natl. Acad. Sci. USA 1988; 85: 4879-4883.
78. Trelstad RL, Hayashi K, Gross J: Collagen fibrillogenesis: intermediate aggregates and suprafibrillar order. Proc. Natl. Acad. Sci. USA 1976; 73:4027-1031.
79. Kadler KE, Hojima Y, Prockop DJ: Collagen fibrils in vitro grow from pointed tips in the C- to N-terminal direction. Biochem. J. 1990; 268:339-343.
80. Henkel W, Glanville RW: Covalent crosslinking between molecules of type I and type III collagen. The involvement of nonhelical regions of the alpha 1 (I) and alpha 1 (III) chains in the formation of intermolecular crosslinks. Eur. J. Biochem. 1982; 122:205-213.
81. Keene DR, Sakai LY, Bächinger HP, Burgeson RE: Type III collagen can be present on banded collagen fibrils regardless of fibril diameter. J. Cell Biol. 1987; 105:2393-2402.
82. Fleischmajer R, Perlish JS, Olsen BR: The carboxyl-propeptide of type I procollagen in skin fibrillogenesis. J. Invest. Dermatol. 1987; 89:212-215.
83. Miyahara M, Hayashi K, Berger J, Tanzawa K, Njieha FK, Trelstad RL, Prockop DJ: Formation of collagen fibrils by enzymic cleavage of precursors of type I collagen in vitro. J. Biol. Chem. 1984; 259: 9891-9898.
84. Vogel KG, Paulsson M, Heinegård D: Specific inhibition of type I and II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem. J. 1984; 223: 587-597.
85. Vogel KG, Trotter JA: The effect of proteoglycans on the morphology of collagen fibrils formed in vitro. Collagen Rel. Res. 1987; 7:105-114.
86. Speranza ML, Valentini G, Calligaro A: Influence of fibronectin on the fibrillogenesis of type I and type III collagen. Collagen Rel. Res. 1987; 7:115-123.
87. Birk DE, Lande MA: Corneal and scierai collagen fiber formation in vitro. Biochim. Biophys. Acta 1981; 670:362-369.
88. Lapiere CM, Nusgens B, Pierard GE: Interaction between collagen type I and type III in conditioning bundles organization. Connect. Tissue Res. 1977; 5: 21-29.
89. Broek DL, Madri J, Eikenberry EF, Brodsky B: Characterization of the tissue form of type V collagen from chick bone. J. Biol. Chem. 1985; 260:555-562.
90. Birk DE, Zycband EI, Winkelmann DA, Trelstad RL: Collagen fibrillogenesis in situ: discontinuous segmental assembly in extracellular compartments. Ann. N.Y. Acad. Sci. 1990; 580:176-194.
91. Johnson PC, Doll SC: Dermal nerves in human diabetic subjects. Diabetes 1984; 33:244-250.
92. Bradley JL, Thomas PK, King RHM, Muddle JR, Ward JD, Tesfaye S, Boulton AJM, Tsigos C, Yang RJ: Myelinated nerve fibre regeneration in diabetic sensory polyneuropathy: correlation with type of diabetes. Acta Neuropathol. 1995; 90:403-410.
93. Sosenko JM, Miettinen OS, Williamson JR, Gabbay KH: Muscle capillary basement membrane thickness and long-term glycemia in type 1 diabetes mellitus. N. Engl. J. Med. 1984; 311:694-698.
94. Mayhew TM, Sharma AK, McCallum KNC: Effects of continuous subcutaneous insulin infusion on renal morphology in experimental diabetes. II. Glomerular basement membrane thickness. J. Pathol. 1987; 151:157-161.
95. Olgemoller B, Schleicher E: Alterations of glomerular matrix proteins in the pathogenesis of diabetic nephropathy. Clin. Invest. 1993; 71 (Suppl.):S13-S19.
96. Ziyadeh FN: Renal tubular basement membrane and collagen type IV in diabetes mellitus. Kidney Int. 1993; 43:114-120.
97. Nathan DM: The pathophysiology of diabetic complications: how much does the glucose hypothesis explain? Ann. Intern. Med. 1996; 124:86-89.
98. Muona P, Peltonen J, Jaakkola S, Uitto J: Increased matrix gene expression by glucose in rat neural connective tissue cells in culture. Diabetes 1991; 40:605-611.
99. Cagliero E, Maiello M, Boeri D, Roy S, Lorenzi M: Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J. Clin. Invest. 1988; 82:735-738.
100. Cagliero E, Roth T, Roy S, Lorenzi M: Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes 1991; 40:102-110.
101. Ayo SH, Radnik RA, Glass WF II, Garoni JA, Rampt ER, Appling DR, Kreisberg JI: Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am. J. Physiol. 1991; 260:185-191.
102. Ziyadeh FN, Snipes ER, Watanabe M, Alvarez RJ, Goldfarb S, Haverty TP: High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am. J. Physiol. 1990; 259:704-714.
103. Peltonen J, Jaakkola S, Virtanen I, Pelliniemi L: Perineurial cells in culture: an immunocytochemical and electron microscopic study. Lab. Invest. 1987; 57:480-488.
104. Jaakkola S, Peltonen J, Uitto J: Perineurial cells coexpress genes encoding interstitial collagens and basement membrane zone components. J. Cell Biol. 1989; 108:1157-1163.
105. Muona P, Sollberg S, Peltonen J, Uitto J: Glucose transporters of rat peripheral nerve: Differential expression of GLUT-1 gene by Schwann cells and perineurial cells in vivo and in vitro. Diabetes 1992; 41:1587-1596.
106. Ayo SH, Radnik RA, Garoni J, Troyer DA, Kreisberg JI: High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am. J. Physiol. 1991; 261:F571-F577.
107. Craven PA, DeRubertis FR: Protein kinase C is activated in glomeruli from streptozotocin rats. Possible mediation by glucose. J. Clin. Invest. 1989; 83:1667-1675.
108. Kreisberg JI, Radnik RA, Ayo SH, Garoni JA, Saikumar P: High glucose elevates c-fos and c-jun transcripts and proteins in mesangial cell cultures. Kidney Int. 1994; 46:105-112.
109. Ruderman NB, Williamson JR, Brownlee M: Glucose and vascular disease. FASEB J. 1992; 6:2905-2914.
110. Sima AAF, Nathaniel V, Prashar A, Bril V, Greene DA: Endoneurial microvessels in human diabetic neuropathy. Endothelial cell dysjunction and lack of treatment effect by aldose reductase inhibitor. Diabetes 1991; 40:1090-1099.
111. Bleyer AJ, Fumo P, Snipes ER, Goldfarb S, Simmons DA, Ziyadeh FN: Polyol pathway mediates high glucose-induced collagen synthesis in proximal tubule. Kidney Int. 1994; 45:659-666.
112. Brownlee M: Glycation products and the pathogenesis of diabetic complications. Diabetes Care 1992; 15: 1835-1843.
113. Ahmed N, Furth AJ: Failure of common glycation assays to detect glycation by fructose. Clin. Chem. 1992; 38: 1301-1303.
114. Ellis EN, Good BH: Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus. Metabolism 1991; 40:1016-1019.
115. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE: Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 1992; 89:2873-2877.
116. Yang C-W, Vlassara H, Peten EP, He C-J, Striker JI, Striker LJ: Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc. Natl. Acad. Sci. USA 1994; 91:1936-1940.
117. Skolnik EY, Yang Z, Makita Z, Radoff S, Kirstein M, Vlassara H: Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy. J. Exp. Med. 1991; 174:931-939.
118. Roberts AN, Sporn MB: The transforming growth factor-βs. In: Peptide Growth Factors and Their Receptors (Sporn MB, Roberts AB, eds). New York: Springer-Verlag, 1991, pp 419-471.
119. Meyer-Ingold W, Eichner W: Platelet-derived growth factor. Cell Biol. Int. 1995; 19:389-98.
120. McClain DA, Paterson AJ, Roos MD, Wei X, Kudlow JE: Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc. Natl. Acad. Sci. USA 1992; 89:8150-8154.
121. Mizutani M, Okuda Y, Yamaoka T, Tsukahara K, Isaka M, Bannai C, Yamashita K: High glucose and hyperosmolarity increase platelet-derived growth factor mRNA levels in cultured human vascular endothelial cells. Biochem. Biophys. Res. Commun. 1992; 187:664-669.
122. Inaba T, Ishibashi S, Gotoda T, Kawamura M, Morino N, Nojima Y, Kawakami M, Yazaki Y, Yamada N: Enhanced expression of platelet-derived growth factor-beta receptor by high glucose. Involvement of platelet-derived growth factor in diabetic angiopathy. Diabetes 1996; 45:507-512.
123. Kreisberg JI, Garoni JA, Radnik R, Ayo SH: High glucose and TGFβ1 stimulate fibronectin gene expression through a cAMP response element. Kidney Int. 1994; 46:1019-1024.
124. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J. Clin. Invest. 1994; 93:536-542.
125. Sharma K, Jin Y, Guo J, Ziyadeh FN: Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 1996; 45:522-530.
126. Rechthand E, Smith QR, Rapoport SI: Facilitated transport of glucose from blood into peripheral nerve. J. Neurochem. 1985; 45:957-964.
127. Kahn BB: Facilitative glucose transporters: Regulatory mechanisms and dysregulation in diabetes. J. Clin. Invest. 1992; 89:1367-1374.
128. Baldwin SA. Mammalian passive glucose transporters: members of an ubiquitous family of active and passive transport proteins. Biochim. Biophys. Acta 1993; 1154:17-19.
129. Bell GI, Burant CF, Takeda J, Gould GW: Structure and function of mammalian facilitative sugar transporters. J. Biol. Chem. 1993; 268:19161-19164.
130. Mueckler M: Facilitative glucose transporters. Eur. J. Biochem. 1994; 219:713-725.
131. Mueckler M, Caruso C, Baldwin SA, Panico M, Blench I, Morris HR, Allard WJ, Lienhard GE, Lodish HF: Sequence and structure of a human glucose transporter. Science 1985; 229:941-945.
132. Greene DA, Winegrad AI: In vitro studies of the substrates for energy production and the effects of insulin on glucose utilization in the neural components of peripheral nerve. Diabetes 1979; 28:878-887.
133. Froehner SC, Davies A, Baldwin SA, Lienhard GE: The blood-nerve barrier is rich in glucose transporter. J. Neurocytol. 1988; 17:173-178.
134. Gerhart DZ, Drewes LR: Glucose transporters at the blood-nerve barrier are associated with perineurial cells and endoneurial microvessels. Brain Res. 1990; 508:46-50.
135. Muona P, Jaakkola S, Salonen V, Peltonen J: Expression of glucose transporter 1 in adult and developing human peripheral nerve. Diabetologia 1993; 36:133-140.
136. Dyck PJ, Kratz KM, Lehman KA, Karnes JL, Melton LJ III, O'Brien PC, Litchy WJ, Windebank AJ, Smith BE, Low PA, Service FJ, Rizza RA, Zimmerman BR: The Rochester Diabetic Neuropathy Study: Design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 1991; 41:799-807.
137. Vinik AI, Holland MT, Le Beau JM, Liuzzi FJ, Stansberry KB, Cohen LB: Diabetic neuropathies. Diabetes Care 1992; 15:1926-1975.
138. Sima AAF: Review: pathogenesis, progression, and therapeutic intervention of diabetic neuropathy. J. Ocul. Pharmacol. 1992; 8:173-181.
139. Calissi PT, Jaber LA: Peripheral diabetic neuropathy: current concepts in treatment. Ann. Pharmacother. 1995; 29:769-77.
140. Tesfaye S, Harris N, Jakubowski JJ, Mody C, Wilson RM, Rennie IG, Ward JD: Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia 1993; 36:1266-1274.
141. Tesfaye S, Malik R, Ward JD: Vascular factors in diabetic neuropathy. Diabetologia 1994; 37:847-854.
142. Ohi T, Poduslo JF, Dyck PJ: Increased endoneurial albumin in diabetic polyneuropathy. Neurology 1985; 35:1790-1791.
143. Ziyadeh FN: The extracellular matrix in diabetic nephropathy. Am. J. Kidney Dis. 1993; 22:736-744.
144. Tsilibary EC, Charonis AS, Reger LA, Wohlhueter RM, Furcht LT: The effect of nonenzymatic glycosylation on the binding of the main noncollagenous NC1 domain to type IV collagen. J. Biol. Chem. 1988; 263: 4302-4308.
145. Tarsio JF, Reger LA, Furcht LT: Molecular mechanisms in basement membrane complications of diabetes. Alterations in heparin, laminin, and type IV collagen association. Diabetes 1988; 37:532-539.
146. Anderson SS, Tsilibary EC, Charonis AS: Nonenzymatic glycosylation-induced modifications of intact bovine kidney tubular basement membrane. J. Clin. Invest. 1993; 92:3045-3052.
147. Shimomura H, Spiro RG: Studies on macromolecular components of human glomerular basement membranes and alterations in diabetes. Decreased levels of heparan sulfate proteoglycan and laminin. Diabetes 1987; 36:374-381.
148. Federoff HJ, Lawrence D, Brownlee M: Nonenzymatic glycosylation of laminin and the laminin peptide CIKVAVS inhibits neurite outgrowth. Diabetes 1993; 42:509-513.
149. Bunge MB, Bunge RP: Linkage between Schwann cell extracellular matrix production and ensheathment function. Ann. N.Y. Acad. Sci. 1986; 486:214-247.
150. Roth T, Podesta F, Stepp MA, Boeri D, Lorenzi M: Integrin overexpression induced by high glucose and by human diabetes: potential pathway to cell dysfunction in diabetic microangiopathy. Proc. Natl. Acad. Sci. USA 1993; 90:9640-9644.
151. Hasegawa G, Hunter AJ, Charonis AS: Matrix nonenzymatic glycosylation leads to altered cellular phenotype and intracellular tyrosine phosphorylation. J. Biol. Chem. 1995; 270:3278-3283.
152. Anderson SS, Kim Y, Tsilibary EC: Effects of matrix glycation on mesangial cell adhesion, spreading and proliferation. Kidney Int. 1994; 46:1359-1367.